Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

Dr Liz O’Riordan, a breast cancer surgeon and three-time cancer patient, shares the surprising things that raise the risk of ...